William Maughan
Stock Analyst at Clear Street
(4.17)
# 1,558
Out of 5,078 analysts
145
Total ratings
42.4%
Success rate
11.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by William Maughan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OCUL Ocular Therapeutix | Reiterated: Buy | $28 | $6.50 | +330.77% | 8 | Aug 18, 2026 | |
| KRRO Korro Bio | Reiterated: Buy | $18 | $11.98 | +50.25% | 6 | Aug 7, 2026 | |
| BEAM Beam Therapeutics | Reiterated: Buy | $37 | $24.05 | +53.85% | 6 | Aug 5, 2026 | |
| DNTH Dianthus Therapeutics | Reiterated: Buy | $130 | $76.78 | +69.31% | 3 | Aug 5, 2026 | |
| KRYS Krystal Biotech | Reiterated: Buy | $338 → $311 | $311.50 | -0.16% | 5 | May 4, 2026 | |
| SMMT Summit Therapeutics | Reiterated: Buy | $32 → $31 | $15.47 | +100.39% | 6 | May 1, 2026 | |
| WVE Wave Life Sciences | Reiterated: Buy | $39 → $36 | $3.18 | +1,032.08% | 7 | Apr 28, 2026 | |
| ANNX Annexon | Reiterated: Buy | $17 | $3.75 | +353.33% | 2 | Mar 30, 2026 | |
| CLLS Cellectis | Reiterated: Buy | $9 | $0.98 | +818.37% | 2 | Mar 20, 2026 | |
| IPSC Century Therapeutics | Reiterated: Buy | $6.6 | $1.46 | +352.05% | 10 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $3.67 | +117.98% | 4 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $181 → $167 | $88.12 | +89.53% | 21 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4.6 | $2.40 | +91.67% | 3 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $0.5328 | +2,339.94% | 2 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $6.68 | +573.65% | 4 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 → $27 | $14.42 | +87.24% | 11 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $45 → $50 | $49.39 | +1.24% | 4 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $67 | $30.98 | n/a | 4 | May 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $6.41 | n/a | 6 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $9 | $2.11 | n/a | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $15 | $1.79 | n/a | 5 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 | $25.18 | n/a | 5 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $91 → $106 | $200.10 | n/a | 7 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $3.55 | n/a | 7 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $10 → $5 | $23.55 | n/a | 2 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $250.69 | n/a | 1 | Sep 5, 2022 |
Ocular Therapeutix
Aug 18, 2026
Reiterated: Buy
Price Target: $28
Current: $6.50
Upside: +330.77%
Korro Bio
Aug 7, 2026
Reiterated: Buy
Price Target: $18
Current: $11.98
Upside: +50.25%
Beam Therapeutics
Aug 5, 2026
Reiterated: Buy
Price Target: $37
Current: $24.05
Upside: +53.85%
Dianthus Therapeutics
Aug 5, 2026
Reiterated: Buy
Price Target: $130
Current: $76.78
Upside: +69.31%
Krystal Biotech
May 4, 2026
Reiterated: Buy
Price Target: $338 → $311
Current: $311.50
Upside: -0.16%
Summit Therapeutics
May 1, 2026
Reiterated: Buy
Price Target: $32 → $31
Current: $15.47
Upside: +100.39%
Wave Life Sciences
Apr 28, 2026
Reiterated: Buy
Price Target: $39 → $36
Current: $3.18
Upside: +1,032.08%
Annexon
Mar 30, 2026
Reiterated: Buy
Price Target: $17
Current: $3.75
Upside: +353.33%
Cellectis
Mar 20, 2026
Reiterated: Buy
Price Target: $9
Current: $0.98
Upside: +818.37%
Century Therapeutics
Mar 13, 2026
Reiterated: Buy
Price Target: $6.6
Current: $1.46
Upside: +352.05%
Mar 13, 2026
Reiterated: Buy
Price Target: $8
Current: $3.67
Upside: +117.98%
Mar 11, 2026
Reiterated: Buy
Price Target: $181 → $167
Current: $88.12
Upside: +89.53%
Mar 10, 2026
Reiterated: Buy
Price Target: $4.6
Current: $2.40
Upside: +91.67%
Mar 6, 2026
Reiterated: Buy
Price Target: $13
Current: $0.5328
Upside: +2,339.94%
Mar 6, 2026
Reiterated: Buy
Price Target: $45
Current: $6.68
Upside: +573.65%
Feb 26, 2026
Reiterated: Buy
Price Target: $29 → $27
Current: $14.42
Upside: +87.24%
Nov 11, 2025
Reiterated: Hold
Price Target: $45 → $50
Current: $49.39
Upside: +1.24%
May 23, 2024
Reiterated: Hold
Price Target: $67
Current: $30.98
Upside: n/a
May 15, 2024
Reiterated: Buy
Price Target: $24
Current: $6.41
Upside: n/a
May 9, 2024
Reiterated: Buy
Price Target: $11 → $9
Current: $2.11
Upside: n/a
May 9, 2024
Reiterated: Buy
Price Target: $16 → $15
Current: $1.79
Upside: n/a
May 9, 2024
Reiterated: Buy
Price Target: $38
Current: $25.18
Upside: n/a
May 3, 2024
Reiterated: Hold
Price Target: $91 → $106
Current: $200.10
Upside: n/a
Feb 20, 2024
Reiterated: Buy
Price Target: $60
Current: $3.55
Upside: n/a
Nov 15, 2022
Downgraded: Hold
Price Target: $10 → $5
Current: $23.55
Upside: n/a
Sep 5, 2022
Reiterated: Buy
Price Target: n/a
Current: $250.69
Upside: n/a